These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35844887)

  • 1. Epidemiological Characteristics of COVID-19 and Effective Public Health Interventions in Shenzhen, China.
    Li G; Lin J; Xu D
    Front Public Health; 2022; 10():923175. PubMed ID: 35844887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen.
    Zou X; Xu ZQ; Wang HR; Wang BX; He JF; Wang JZ
    BMC Public Health; 2021 Mar; 21(1):551. PubMed ID: 33743630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020.
    Wang Y; Yu J; Wang F; Zhang Y; Ma S
    Front Public Health; 2023; 11():1151038. PubMed ID: 37089485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong-January to May 2020.
    Lam HY; Lam TS; Wong CH; Lam WH; Leung CME; Au KWA; Lam CKY; Lau TWW; Chan YWD; Wong KH; Chuang SK
    Int J Infect Dis; 2020 Sep; 98():51-58. PubMed ID: 32579906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission dynamics and successful control measures of SARS-CoV-2 in the mega-size city of Guangzhou, China.
    Zhao H; Zhang Z; Lun W; Chen Z; Lu X; Li J; Qiu F; Li S; Mao C; Lu Y; Chen J; He Q; Lu J; Yang Z
    Medicine (Baltimore); 2021 Dec; 100(48):e27846. PubMed ID: 35049185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the comprehensive non-pharmaceutical interventions and measures in containing the COVID-19 epidemic in Shenzhen: a retrospective study.
    Xu S; Liu P; Mei S; Lv Q; Cheng C; Lu Y; Kong D; Wu X; Wen Y; Cao B; Gao S; Xiong H; Zhao J; Huang Y; Luo Y; Feng T
    BMJ Open; 2021 Jul; 11(7):e044940. PubMed ID: 34312193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of the characteristics of imported COVID-19 cases from January to April in 2020: a cross-sectional study.
    Huang J; Chen SW; Han N; Liu ZM; Xiao WW; Jiang BQ; Han MX
    Ann Transl Med; 2022 Oct; 10(20):1131. PubMed ID: 36388784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Coronavirus Disease 2019 Community Containment Strategies in Shenzhen, China.
    Zhang XM; Zhou HE; Zhang WW; Dou QL; Li Y; Wei J; Hu R; Liu J; Cheng ASK
    JAMA Netw Open; 2020 Jun; 3(6):e2012934. PubMed ID: 32568401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological clustered characteristics of coronavirus disease 2019 (COVID-19) in three phases of transmission in Jilin Province, China.
    Zhao Q; Zhang Y; Li M; Tian R; Zhao Y; Cao B; Yao L; Sheng X; Yu Y
    PLoS One; 2023; 18(1):e0279879. PubMed ID: 36656818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of work resumption strategies after COVID-19 reopening in the Chinese city of Shenzhen: a mathematical modeling study.
    Bai L; Lu H; Hu H; Smith MK; Harripersaud K; Lipkova V; Wen Y; Guo X; Peng W; Liu C; Shen M; Shen AC; Zhang L
    Public Health; 2021 Apr; 193():17-22. PubMed ID: 33706208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soaring Asymptomatic Infected Individuals Bring About Barriers and Difficulties for Interruption of COVID-19 Prevalence in China.
    Chen M; Ai L; Huang D; Chen J; Feng T; Mei S; Huang Y; Peng B; Zhang S; Zhang R; Zhou X
    Vector Borne Zoonotic Dis; 2021 Oct; 21(10):777-784. PubMed ID: 34375121
    [No Abstract]   [Full Text] [Related]  

  • 12. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19.
    Zou H; Shu Y; Feng T
    Infect Dis Poverty; 2020 Jul; 9(1):89. PubMed ID: 32650840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics of COVID-19 in Shenzhen, China: comparison between imported and local cases.
    Li Z; Wang J; Huang J; Lu J
    J Infect Dev Ctries; 2020 Aug; 14(8):853-860. PubMed ID: 32903229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Assessment of Importation and Local Transmission of COVID-19 in South Korea: Statistical Modeling Approach.
    Lee H; Kim Y; Kim E; Lee S
    JMIR Public Health Surveill; 2021 Jun; 7(6):e26784. PubMed ID: 33819165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and Control Measures for Imported SARS-CoV-2 Transmission During the Postpandemic Period in Shenzhen, China.
    He X; Gong F; Sun X; Hu G; Lin J
    Disaster Med Public Health Prep; 2022 Mar; 17():e143. PubMed ID: 35241200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.
    Zhang J; Wu S; Xu L
    Biosci Trends; 2020 Jul; 14(3):206-208. PubMed ID: 32321904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
    Cheng S; Zhao Y; Kaminga AC; Zhang X; Xu H
    Front Public Health; 2022; 10():548056. PubMed ID: 35844877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological characteristics and quarantine assessment of imported international COVID-19 cases, March to December 2020, Chengdu, China.
    Zhang W; Yue Y; Hu M; Du C; Wang C; Tuo X; Jiang X; Fan S; Chen Z; Chen H; Liang X; Luan R
    Sci Rep; 2022 Dec; 12(1):21132. PubMed ID: 36477091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.